Abe Kazumichi, Takahashi Atsushi, Imaizumi Hiromichi, Hayashi Manabu, Okai Ken, Kanno Yukiko, Watanabe Hiroshi, Ohira Hiromasa
Department of Gastroenterology and Rheumatology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima 960-1295 Japan.
Springerplus. 2016 Jun 18;5(1):777. doi: 10.1186/s40064-016-2512-y. eCollection 2016.
Recently, the number of follicular helper T (Tfh) cells expressing interleukin (IL)-21 was found to increase in peripheral blood of human and murine models of autoimmune hepatitis (AIH). IL-21, the most recently discovered member of the type-I cytokine family, exerts various effects on the immune system, including B cell activation, plasma cell differentiation, and immunoglobulin production. We aimed to assess the relationship of serum IL-21 levels in patients with type I AIH with clinical and laboratory parameters and histology.
Ninety-two Japanese patients with liver disease (22 AIH, 20 primary biliary cholangitis, 19 drug-induced liver injury, 8 acute hepatitis B, 8 chronic hepatitis C, 10 non-alcoholic steatohepatitis, 5 viral hepatitis) and 10 healthy volunteers were recruited. Serum IL-21 levels were detected by enzyme-linked immunosorbent assay. Real-time polymerase chain reaction measured mRNA levels of Bcl-6, IL-21, and CXCR5 (Tfh-related factors) in peripheral mononuclear cells.
Mean age at diagnosis of AIH was 58.6 years, male-to-female ratio was 4:18, 18.2 % of participants had cirrhosis, and 22.7 % had severe disease. IL-21 levels were significantly increased in the serum of patients with AIH compared to those with other liver diseases and controls (p < 0.0001). Particularly, serum IL-21 levels were significantly increased in severe AIH cases compared to non-severe cases (p < 0.05). Serum IL-21 levels correlated positively with total serum bilirubin levels (r = 0.46, p < 0.05), grading of necroinflammatory activity (r = 0.68, p < 0.005) and negatively with serum albumin levels in patients with AIH (r = -0.49, p < 0.05). In patients with biochemical remission of AIH, serum IL-21 levels remained elevated and correlated positively with serum IgG levels (r = 0.84, p < 0.01). Expression of Tfh-related factors, such as Bcl-6 and IL-21, in peripheral blood mononuclear cells of patients with AIH was significantly higher than that in healthy volunteers.
IL-21 may play an important role in the pathogenesis and severity of AIH, and may present a promising target for AIH therapy.
最近发现,在自身免疫性肝炎(AIH)的人类和小鼠模型外周血中,表达白细胞介素(IL)-21的滤泡辅助性T(Tfh)细胞数量增加。IL-21是I型细胞因子家族中最新发现的成员,对免疫系统有多种作用,包括B细胞活化、浆细胞分化和免疫球蛋白产生。我们旨在评估I型AIH患者血清IL-21水平与临床、实验室参数及组织学之间的关系。
招募了92名日本肝病患者(22例AIH、20例原发性胆汁性胆管炎、19例药物性肝损伤、8例急性乙型肝炎、8例慢性丙型肝炎、10例非酒精性脂肪性肝炎、5例病毒性肝炎)和10名健康志愿者。采用酶联免疫吸附测定法检测血清IL-21水平。通过实时聚合酶链反应测定外周血单核细胞中Bcl-6、IL-21和CXCR5(与Tfh相关的因子)的mRNA水平。
AIH患者诊断时的平均年龄为58.6岁,男女比例为4:18,18.2%的参与者有肝硬化,22.7%有严重疾病。与其他肝病患者和对照组相比,AIH患者血清中的IL-21水平显著升高(p < 0.0001)。特别是,与非严重AIH病例相比,严重AIH病例的血清IL-21水平显著升高(p < 0.05)。AIH患者血清IL-21水平与血清总胆红素水平呈正相关(r = 0.46,p < 0.05),与坏死性炎症活动分级呈正相关(r = 0.68,p < 0.005),与血清白蛋白水平呈负相关(r = -0.49,p < 0.05)。在AIH生化缓解的患者中,血清IL-21水平仍升高,并与血清IgG水平呈正相关(r = 0.84,p < 0.01)。AIH患者外周血单核细胞中Tfh相关因子如Bcl-6和IL-21的表达明显高于健康志愿者。
IL-21可能在AIH的发病机制和严重程度中起重要作用,可能是AIH治疗的一个有前景的靶点。